echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature Immunology: Rapid response signal platform provides a new way to block allergic inflammation

    Nature Immunology: Rapid response signal platform provides a new way to block allergic inflammation

    • Last Update: 2021-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Picture: Details the mechanism of the body's allergen perception system


    Source: Cincinnati Children

    When people come into contact with allergens such as insects, mites and fungi, the built-in rapid response system will trigger an inflammatory response.


    A study led by scientists at Cincinnati Children's Hospital was published in Nature Immunology on September 16, 2021, revealing new details about how the body's "type 2 innate immune response" system works


    "Blocking the allergen perception pathway can provide a unique opportunity to combat type 2 immunity and relieve allergic inflammation," said Marc Rothenberg, MD, director of the Cincinnati Children's Allergy and Immunity Department and senior author of the study


    In addition to Rothenberg, the research team also includes Michael Brusilovsky, Dr.


    Previous studies have confirmed that a variety of allergens can induce similar IL-33 responses when destroying the mucosal epithelial layer


    Allergen Sensing System

    Brusilovsky, the first author of the study, said: "This breakthrough was possible because of new insights into the role of ripoptosome signaling and caspases in allergic inflammation


    Specifically, allergens trigger activity in a chain of cell death-inducing signals called ribonucleic acid


    In the past two decades, immunologists have discovered the mechanism by which the innate immune system perceives bacteria and viruses, but how to perceive allergens is still a mystery


    "The discovery of this surprising mechanism is the most important breakthrough in understanding how the innate immune system perceives allergens to initiate type 2 reactions and subsequent allergic inflammation," said Pasare, one of the study's senior authors


    In mice, inhibiting the activity of caspase 8 reduced IL-33's response to allergen exposure and limited bronchial inflammation in the lungs


    "In the human allergic disease eosinophilic esophagitis (EoE), we found that ripoptosome activation markers and mature IL-33 levels are dynamically correlated with esophageal eosinophilia and the degree of disease activity," the study said


    The next step involves further confirming the RipIL-33 pathway in human allergic reactions and determining whether existing drugs or new compounds can safely disrupt the inflammatory cycle


    Original Search

    DOI

    10.


    Environmental allergens trigger type 2 inflammation through ripoptosome activation'


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.